Quarterly report pursuant to Section 13 or 15(d)

Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)

v3.4.0.3
Note 1 - History and Basis of Presentation: Income/loss Per Common Share: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2016
Tables/Schedules  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following instruments are currently antidilutive and have been excluded from the calculations of diluted income or loss per share at March 31, 2016 and 2015, as follows:

 

 

March 31,

 

2016

2015

 

 

 

Convertible notes and accrued interest

25,000,000

24,100,000

Convertible preferred stock - Series B

11,818,181

11,818,181

Warrants

3,083,332

3,083,332

Compensation-based stock options and warrants

91,558,997

88,682,003

 

131,460,510

127,683,516